Chitra Venugopal, Ph.D.
Affiliations: | 2008 | Medical University of South Carolina, Charleston, SC, United States |
Area:
Neuroscience BiologyGoogle:
"Chitra Venugopal"Mean distance: 53433
Parents
Sign in to add mentorKumar Sambamurti | grad student | 2008 | MUSC | |
(Amyloid precursor protein metabolism and Alzheimer's disease.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hegde ML, Bharathi P, Suram A, et al. (2009) Challenges associated with metal chelation therapy in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 17: 457-68 |
Venugopal C, Demos CM, Rao KS, et al. (2008) Beta-secretase: structure, function, and evolution. Cns & Neurological Disorders Drug Targets. 7: 278-94 |
Zhou Y, Suram A, Venugopal C, et al. (2008) Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 47-54 |
Sambamurti K, Prakasam A, Jayachandran AD, et al. (2008) P1-412: Isoprenoids phenocopy familial Alzheimer's disease mutations and regulate gamma-secretase Alzheimer's & Dementia. 4: T340-T340 |
Venugopal C, Pappolla MA, Sambamurti K. (2007) Insulysin cleaves the APP cytoplasmic fragment at multiple sites. Neurochemical Research. 32: 2225-34 |
Suram A, Venugopal C, Prakasam A, et al. (2006) Genotoxicity in Alzheimer's disease: role of amyloid. Current Alzheimer Research. 3: 365-75 |
Sambamurti K, Suram A, Venugopal C, et al. (2006) A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis. Current Alzheimer Research. 3: 81-90 |
Sambamurti K, Prakasam A, Anitha S, et al. (2006) P2-417: Oral phenserine tartrate treatment is associated with reduced plasma Abeta 1-42 in a phase I clinical study Alzheimer's & Dementia. 2: S369-S370 |